Clinical Trials Directory

Trials / Unknown

UnknownNCT05848986

Study if the Presence of Functional FcERI/RII on the Surface of Human Blood Platelet

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Anaphylactic shock is the most severe expression of immediate hypersensitivity reactions. The mechanisms leading to these reactions are still poorly understood and may involve platelets, especially in the most severe forms. The IgE ( ImmunoglobulineE)-mediated mechanism, involving the FcERI(the high-affinity receptor for the Fc region of immunoglobulin E (IgE) receptor present on the surface of mast cells and basophilic cells, is the most common mechanism. The receptors FcERI and FcERII are also described as being present on the surface of blood platelets, which would imply their activation along with the other cells involved. However, studies showing the presence of the FcERI/RII receptors on blood platelets suffer from many biases. The main objective of the research is to study whether the FcERI/RII receptors are present and functional on the surface of blood platelets from allergic patients.

Conditions

Interventions

TypeNameDescription
OTHERFlow cytometryAnalysis of blood samples from a health sample's allergic patients and analysis with flow cytometry

Timeline

Start date
2023-06-01
Primary completion
2023-06-01
Completion
2025-04-01
First posted
2023-05-08
Last updated
2023-05-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05848986. Inclusion in this directory is not an endorsement.